Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H14AsNO3S2 |
| Molecular Weight | 347.285 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)NC1=CC(=CC=C1O)[As]2SCC(CO)S2
InChI
InChIKey=MRUDSZSRLQAPOG-UHFFFAOYSA-N
InChI=1S/C11H14AsNO3S2/c1-7(15)13-10-4-8(2-3-11(10)16)12-17-6-9(5-14)18-12/h2-4,9,14,16H,5-6H2,1H3,(H,13,15)
| Molecular Formula | C11H14AsNO3S2 |
| Molecular Weight | 347.285 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The antitumor effects of an arsthinol-cyclodextrin complex in a heterotopic mouse model of glioma. | 2013-11 |
|
| Intestinal amebiasis; incidence, symptoms, and treatment with arsthinol (balarsen). | 1956-02-04 |
|
| The treatment of amebiasis with arsthinol (N.N.R) (balarsen). | 1954-06 |
|
| Arsthinol (balarsen), a new trivalent arsenical for the treatment of intestinal amebiasis and other intestinal protozoa. | 1954-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:51:35 GMT 2025
by
admin
on
Mon Mar 31 17:51:35 GMT 2025
|
| Record UNII |
QNT09A162Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
P01AR01
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
||
|
WHO-VATC |
QP51AD01
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3007
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
QNT09A162Y
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
DTXSID40861753
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
DB08928
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
8414
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
ARSTHINOL
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
240
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
SUB05572MIG
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
100000086623
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
C76411
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
C546471
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
119-96-0
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | |||
|
m2072
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
204-361-7
Created by
admin on Mon Mar 31 17:51:35 GMT 2025 , Edited by admin on Mon Mar 31 17:51:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |